v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue:        
Total revenue $ 88 $ 836 $ 198 $ 1,704
Expenses:        
Cost of product revenues 25 46 57 90
Research and development 16,590 13,853 32,371 27,335
Selling, general and administrative 5,829 6,264 12,202 12,527
Total expenses 22,444 20,163 44,630 39,952
Loss from operations (22,356) (19,327) (44,432) (38,248)
Other (expense) income:        
Interest (expense) income, net (1,768) (36) (2,589) 130
Change in the fair value of derivative liability 324   289  
Gain on sale of strategic investments 45   2,286  
Total other (expense) income (1,399) (36) (14) 130
Net loss (23,755) (19,363) (44,446) (38,118)
Adjustment to carrying value of Series A Preferred Stock (324)   (289)  
Net loss attributable to common stockholders $ (24,079) $ (19,363) $ (44,735) $ (38,118)
Net loss attributable to common stockholders per share        
Basic (in dollars per share) $ (0.38) $ (0.5) $ (0.72) $ (0.99)
Diluted (in dollars per share) $ (0.38) $ (0.5) $ (0.72) $ (0.99)
Weighted-average shares used in computing net loss attributable to common stockholders per share, basic (in shares) 63,812,098 38,392,716 62,019,963 38,314,936
Weighted-average shares used in computing net loss attributable to common stockholders per share, diluted (in shares) 63,812,098 38,392,716 62,019,963 38,314,936
Comprehensive loss        
Net loss $ (23,755) $ (19,363) $ (44,446) $ (38,118)
Unrealized loss on marketable securities (41) (21) (141) (36)
Comprehensive loss (23,796) (19,384) (44,587) (38,154)
Partnership revenue        
Revenue:        
Total revenue   667   1,399
Product revenue        
Revenue:        
Total revenue $ 88 $ 169 $ 198 $ 305